Trending...
- Spokane: City Construction Projects Traffic Impacts Next Week
- Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
SEATTLE ~ AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has been awarded a special mention for Research and Innovation led by Executives Under the Age of 40 by Confindustria. Confindustria is the main association representing manufacturing and service companies in Italy, with a voluntary membership of more than 150,000 companies of all sizes, employing a total of 5,383,286 people.
The AGC Biologics Milan site has a strong team of life science professionals, with 72% of the workforce being under the age of 40. The site's leadership promotes a dynamic and diverse environment to support these team members in their mission to help pharmaceutical companies bring lifesaving treatments to market. 80% at the site hold college degrees, and among those, 16% have achieved a PhD. 61% of leadership positions are held by women.
Francesco De Santis, Vice President of Confindustria for Research and Development noted that "the award is a recognition of companies that have stood out for the quality of innovation" and that "a national commitment is necessary to go with this process and make the national research, development, and innovation system increasingly integrated".
More on Washingtoner
Luca Alberici from AGC Biologics Milan said "this award showcases the work and potential of our business and the young professionals here in Milan that help make our site so successful". He added that "our entire team is driven by innovation in the workplace and delivering the highest level of quality in our work, to ensure patients get the treatments they need".
AGC Biologics acquired its Milan site (formerly MolMed S.p.A.) to add a cell and gene CDMO business to its offerings in July 2020; it has since become the global hub for their cell and gene therapy services. The team at this site has brought multiple products from pre-clinical through commercial phases as well as developed custom plug-and-play systems for vector manufacturing such as AGC's BravoAAV™ and ProntoLVV™ platforms.
The award from Confindustria recognizes AGC Biologics' commitment to research & development as well as their dedication to providing innovative solutions for their clients while also promoting diversity within their workforce.
The AGC Biologics Milan site has a strong team of life science professionals, with 72% of the workforce being under the age of 40. The site's leadership promotes a dynamic and diverse environment to support these team members in their mission to help pharmaceutical companies bring lifesaving treatments to market. 80% at the site hold college degrees, and among those, 16% have achieved a PhD. 61% of leadership positions are held by women.
Francesco De Santis, Vice President of Confindustria for Research and Development noted that "the award is a recognition of companies that have stood out for the quality of innovation" and that "a national commitment is necessary to go with this process and make the national research, development, and innovation system increasingly integrated".
More on Washingtoner
- Spokane City Council Hosts A Community Food Drive
- OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
- Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
- Valentine Roofing Wins Top Honors in Best in the Pacific Northwest Awards
- Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
Luca Alberici from AGC Biologics Milan said "this award showcases the work and potential of our business and the young professionals here in Milan that help make our site so successful". He added that "our entire team is driven by innovation in the workplace and delivering the highest level of quality in our work, to ensure patients get the treatments they need".
AGC Biologics acquired its Milan site (formerly MolMed S.p.A.) to add a cell and gene CDMO business to its offerings in July 2020; it has since become the global hub for their cell and gene therapy services. The team at this site has brought multiple products from pre-clinical through commercial phases as well as developed custom plug-and-play systems for vector manufacturing such as AGC's BravoAAV™ and ProntoLVV™ platforms.
The award from Confindustria recognizes AGC Biologics' commitment to research & development as well as their dedication to providing innovative solutions for their clients while also promoting diversity within their workforce.
Filed Under: Business
0 Comments
Latest on Washingtoner
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- GlobalBoost (BSTY) Surges 30% Ahead of Biconomy Exchange Listing
- City of Spokane Tourism and Cultural Investment Committee Wins State Tourism Award
- Oom Yung Doe Traditional Martial Arts Tournament
- Tacoma: Mid-Biennium Budget Modification (Mid-Mod) Update Frequently Asked Questions
- White Glove Restoration Sends "Help in Boxes" to Support Communities in Ghana
- Tacoma: Homicide Investigation and Arrest – 3700 South Orchard
- NASA Agreements, New Ocean Exploration Applications Added to Partnerships with Defiant Space Corp and Emtel Energy USA for Solar Tech Leader: $ASTI
- Spokane: SPD Asking for Assistance Locating Missing Elderly Male
- Spokane: Council Member Zappone Responds to County Public Safety Leaders
- Chic and Secure: The Blue Luna Debuts Stylish Keychains with Purpose
- BEC Technologies Showcases Leadership in Private Broadband Ecosystem with Inclusion in UTC's Ecosystem Summary Report
- $500,000 in Stock Dividend for Shareholders in 2025 Sweetens The Pot on Success of Becoming Debt Free with No Convertible Notes or Warrants for $IQST
- Milwaukee Job Corps Center: Essential Workforce Training—Admissions Now Open
- Aissist.io Launches Hybrid AI Workforce to Solve AI Pilot Failure for Customer Support Automation
- Christy Sports Makes Snowsports More Accessible for Families to Get Outside Together
- MainConcept Completes Management Buyout to Become Independent Company
- LIB Industry Expands Full-Series Salt Spray Corrosion Test Chambers to Meet Global Testing Standards